Products for Research Use Only
RegisterLogin

PF-3758309

CAT: 0013-GTR19169750-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19169750-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PF-3758309
CAS Number
898044-15-0
Product Name Alternative
Apoptosis, ATP-competitive, oncogenic, PAK, PAK1, PAK3, PAK4, PAK6, PAK5, inhibit, Inhibitor, growth, proliferation, survival, p21 activated kinases, PF03758309, PF-03758309, PF309, PF-309, PF3758309, PF-3758309, PF 3758309, PF 309, PF 03758309, signaling, tumor
Field of Research
Cell Biology, Signal Transduction
Purity
97.70% (May vary between batches)
Solubility
DMSO:91 mg/mL (185.48 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.73 mM) ; Ethanol:91 mg/mL (185.48 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CN (C) C[C@@H] (NC (=O) N1Cc2c (Nc3nc (C) nc4ccsc34) n[nH]c2C1 (C) C) c1ccccc1
Molecular Formula
C25H30N8OS
Molecular Weight
490.62
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

PF-3758309

PF-3758309 is a member of the class of thienopyrimidines that is thieno[3,2-d]pyrimidine substituted by methyl and (5-{[(1S)-2-(dimethylamino)-1-phenylethyl]carbamoyl}-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)amino groups at positions 2 and 4, respectively. It is a potent inhibitor of PAK4 and inhibits the growth of multiple human tumor xenografts. It has a role as an antineoplastic agent, an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor and an apoptosis inducer. It is a thienopyrimidine, a member of benzenes, a pyrrolopyrazole, a member of ureas, a secondary amino compound and a tertiary amino compound.

CAS Number898044-15-0
PubChem CID25227462
IUPAC NameN-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-d]pyrazole-5-carboxamide
Molecular FormulaC25H30N8OS
Molecular Weight490.6
XLogP3.1
Topological Polar Surface Area130
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Heavy Atom Count35
Formal Charge0
Complexity747
SMILES
CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)N[C@H](CN(C)C)C5=CC=CC=C5)SC=C2
InChI
InChI=1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1
InChIKey
AYCPARAPKDAOEN-LJQANCHMSA-N
Chemical Structure
2D Structure
2D structure of PF-3758309
CAS: 898044-15-0
CID: 25227462
Formula: C25H30N8OS
MW: 490.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight490.6
XLogP33.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass490.22632878
Monoisotopic Mass490.22632878
Topological Polar Surface Area130 Ų
Heavy Atom Count35
Formal Charge0
Complexity747
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19224314-01PF-06745013
GTR19222974-01PF-06764427
GTR19218956-01PF-07208254
GTR19218556-01PF-07059013
GTR19213053-01PF-17
GTR19212475-01PF-06455943
GTR19211449-01PF-446687
GTR19210318-01PF-4211
GTR19209610-01PF-06658607
GTR19209586-01PF-303

Alternative Products

CatalogName
T6626-01PF-3758309
A11930-100PF-3758309 100mg
A11930-25PF-3758309 25mg
A11930-5PF-3758309 5mg

Popular Products